{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:03:34Z","timestamp":1784577814434,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jogc.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T08:01:21Z","timestamp":1473926481000},"page":"742-762.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["RETIRED: Joint SOGC\u2013CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing"],"prefix":"10.1016","volume":"38","author":[{"given":"R. Douglas","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"De Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Campagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June C.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Zwingerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2016.06.008_bib1","unstructured":"Harper PS. Practical genetic counselling, Seventh Edition. Chapter 7 Carrier Testing and Genetic Prediction. CRC Press; 2010. pp. 102\u201314, 283."},{"key":"10.1016\/j.jogc.2016.06.008_bib2","series-title":"Public Health Papers, No. 34","article-title":"Principles and practice of screening for diseases","author":"Wilson","year":"1968"},{"key":"10.1016\/j.jogc.2016.06.008_bib3","series-title":"What is direct-to-consumer genetic testing?","author":"Genetics Home Reference","year":"2016"},{"key":"10.1016\/j.jogc.2016.06.008_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bpobgyn.2012.04.001","article-title":"Reproductive decisions after fetal genetic counselling","volume":"26","author":"Pergament","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2016.06.008_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.fertnstert.2015.06.016","article-title":"Expanded preconception carrier screening in clinical practice: cutting the Gordian Knot","volume":"104","author":"Lindheim","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2016.06.008_bib6","series-title":"Canada has no national standard for newborn screening: here\u2019s why it should","author":"Andreatta","year":"2013"},{"key":"10.1016\/j.jogc.2016.06.008_bib7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ejhg.2014.238","article-title":"An easy test but a hard decision: ethical issues concerning non-invasive prenatal testing for autosomal recessive disorders","volume":"23","author":"Skirton","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s10897-014-9725-4","article-title":"Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis","volume":"23","author":"Hill","year":"2014","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.jogc.2016.06.008_bib9","series-title":"Oxford desk reference clinical genetics","author":"Firth","year":"2005"},{"key":"10.1016\/j.jogc.2016.06.008_bib10","series-title":"Genetic disorders and the fetus: diagnosis, prevention and treatment","author":"Milunsky","year":"2011"},{"key":"10.1016\/j.jogc.2016.06.008_bib11","unstructured":"Canadian Organization for Rare Diseases Newborn Screening in Canada Status Report. Canadian PKU and Allied Disorders Inc. 2015. September 3,\u00a02015."},{"key":"10.1016\/j.jogc.2016.06.008_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1701-2163(16)32975-9","article-title":"Carrier screening for thalassemia and hemoglobinopathies in Canada","volume":"30","author":"Langlois","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.06.008_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1701-2163(16)32949-8","article-title":"Fragile X testing in obstetrics and gynaecology in Canada","volume":"30","author":"Chitayat","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.06.008_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S1701-2163(16)32131-4","article-title":"Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent","volume":"28","author":"Langlois","year":"2006","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.06.008_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1701-2163(16)30196-7","article-title":"Cystic fibrosis carrier testing in pregnancy in Canada","volume":"24","author":"Wilson","year":"2002","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"S2","key":"10.1016\/j.jogc.2016.06.008_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/14767058.2013.829701","article-title":"Prenatal screening and counseling for genetic disorders","volume":"26","author":"Maruotti","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0000000000000267","article-title":"The case for universal prenatal genetic counseling. Current Commentary","volume":"123","author":"Minkoff","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2016.06.008_bib18","first-page":"994","article-title":"Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review","volume":"103","author":"Essop","year":"2013","journal-title":"S\u00a0Af Med J"},{"issue":"1","key":"10.1016\/j.jogc.2016.06.008_bib19","first-page":"e1","article-title":"Prenatal screening for fragile X: carriers, controversies and counseling","volume":"6","author":"Guti\u00e9rrez","year":"2013","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.06.008_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","article-title":"Fragile X syndrome: diagnostic and carrier testing","volume":"7","author":"Sherman","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181fae884","article-title":"ACOG Committee Opinion No. 469: carrier screening for fragile X syndrome","volume":"116","author":"American College of Obstetricians and Gynecologists Committee on Genetics","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"S4","key":"10.1016\/j.jogc.2016.06.008_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/hae.12409","article-title":"Genetic testing in bleeding disorders","volume":"20","author":"De Brasi","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jogc.2016.06.008_bib23","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/hae.12517","article-title":"Prenatal diagnosis in haemophilia A: experience of the genetic diagnostic laboratory","volume":"20","author":"Kessler","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jogc.2016.06.008_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MBC.0000000000000212","article-title":"Carrier and prenatal diagnostic strategy and newly identified mutations in Hungarian haemophilia A and B families","volume":"26","author":"Bors","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jogc.2016.06.008_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10408363.2013.847236","article-title":"Diagnosis and prevention of thalassemia","volume":"50","author":"Ip","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jogc.2016.06.008_bib26","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.3390\/ijerph110606136","article-title":"Genetic epidemiology and preventive healthcare in multiethnic societies: the hemaglobinopathies","volume":"11","author":"Giordano","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jogc.2016.06.008_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ejhg.2014.131","article-title":"EMQN best practice guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies","volume":"23","author":"Traeger-Synodinos","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10897-013-9636-9","article-title":"Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors","volume":"23","author":"Langfelder-Schwind","year":"2014","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.jogc.2016.06.008_bib29","first-page":"1028","article-title":"Committee Opinion No.486. American College of Obstetricians and Gynecologists","volume":"117","author":"Update on carrier screening for Cystic Fibrosis","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.06.008_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10897-015-9833-9","article-title":"\u201cSuddenly having two positive people who are carriers is a whole new thing\u201d \u2013 experiences of couples both identified as carriers of cystic fibrosis through a population-based carrier screening program in Australia","volume":"24","author":"Ioannou","year":"2015","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.jogc.2016.06.008_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/gim.2012.57","article-title":"Report on the p.Ser489X (p.Ser489) CFTR mutation, a variant with severe associated phenotype and high prevalence in a Quebec French-Canadian cystic fibrosis patient population","volume":"14","author":"De Bie","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/GIM.0b013e318164cb1c","article-title":"Distribution of CFTR mutations in Saguenay-Lac-Saint-Jean: proposal of a panel of mutations for population screening","volume":"10","author":"Madore","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ajmg.1320420322","article-title":"Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis","volume":"42","author":"Rozen","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib34","first-page":"115","article-title":"Incidence of cystic fibrosis in Saguenay-Las-St-Jean (Quebec, Canada)","volume":"64","author":"Daigneault","year":"1992","journal-title":"Hum Biol"},{"key":"10.1016\/j.jogc.2016.06.008_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1399-0004.1991.tb03099.x","article-title":"Genetic epidemiology of cystic fibrosis in Saguenay-Lac-St-Jean (Quebec, Canada)","volume":"40","author":"Daigneault","year":"1991","journal-title":"Clin Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.4585","article-title":"Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis","volume":"35","author":"Hill","year":"2015","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.jogc.2016.06.008_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajog.2014.02.001","article-title":"Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze. Clinical Opinion","volume":"211","author":"Ferreira","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.06.008_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM199007053230102","article-title":"Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based testing","volume":"323","author":"Triggs-Raine","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/GIM.0b013e31815f247c","article-title":"Professional practice and guidelines committee. Carrier screening in individuals of Ashkenazi Jewish descent","volume":"10","author":"Gross","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib40","unstructured":"Pastores GM, Hughes DA. Gaucher Disease. Editors Pagon RA, Adam MP, Ardinger HH, et\u00a0al. GeneReviews Seattle (WA) University of Washington, Seattle: 1993-2015. Updated on February 26, 2015. Available at: http:\/\/www.ncbi.nih.gov\/books\/NBK1269\/. Accessed on February 17, 2016."},{"key":"10.1016\/j.jogc.2016.06.008_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1023\/B:BOLI.0000042983.60840.f3","article-title":"Gaucher disease: variability in phenotype among siblings","volume":"27","author":"Amato","year":"2004","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jogc.2016.06.008_bib42","first-page":"93","article-title":"Old meets new: identifying founder mutations in genetic disease","volume":"187","author":"Evans","year":"2015","journal-title":"CMAK"},{"key":"10.1016\/j.jogc.2016.06.008_bib43","first-page":"870","article-title":"Mutational analysis of Tay-Sachs disease carriers of French Canadian background living in New England","volume":"56","author":"Triggs-Raine","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib44","first-page":"161","article-title":"Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff\u2019s disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French Canadian population","volume":"18","author":"Andermann","year":"1977","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jogc.2016.06.008_bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.2005.00497.x","article-title":"Population history and its impact on medical genetics in Quebec","volume":"68","author":"Laberge","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ejhg.2015.256","article-title":"Genetic structure of the Newfoundland and Labrador population: founder effects modulate variability","volume":"24","author":"Zai","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib47","unstructured":"Pouliot S, Gagnon R, Levesque P. Rapport d\u2019evaluation du projet-pilote d\u2019offre de tests de porteur pour quatre maladies hereditaires recessives au Saguenay-Lac-Saint-Jean (July 2014). Available at: https:\/\/www.inspq.qc.ca\/pdf\/publications\/1764_Maladies_hereditaires_saguenay.pdf Accessed on February 17,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib48","unstructured":"Qu\u00e9bec Minist\u00e8re de la Sant\u00e9 et des Services sociaux, Agence de la sant\u00e9 et des services sociaux du Saguenay\u2013Lac-St-Jean. Saguenay-Lac-Saint-Jean: population a effet fondateur. Available at: http:\/\/genetique.santesaglac.com. Accessed on February 17,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410240403","article-title":"Leukoencephaly among native Indian infants in Northern Quebec and Manitoba","volume":"24","author":"Black","year":"1988","journal-title":"Annals Neurol"},{"key":"10.1016\/j.jogc.2016.06.008_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ana.410240402","article-title":"Encephalitis among Cree children in Northern Quebec","volume":"24","author":"Black","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jogc.2016.06.008_bib51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1503\/cmaj.140657","article-title":"Congenital sucrase\u2013isomaltase deficiency: identification of a common Inuit founder mutation","volume":"187","author":"Marcadier","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2016.06.008_bib52","unstructured":"Le Clerc-Blain J, Gosselin V, Bearskin A, Torrie JE, Mitchell GA, Wilson BJ, et\u00a0al. Cree Leukoencephalitis and Cree Encephalitis carrier screening program: evaluation of knowledge and satisfaction of high school students. Available at: http:\/\/www.ashg.org\/2014meeting\/abstracts\/fulltext\/f140120612.htm. Accessed on February 17,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib53","unstructured":"Le Clerc-Blain J, Denoncourt H, Richter A, Laberge AM. Cree Leukoencephalopathy and Cree Encephalitis Carrier Screening Program: lived Experiences of Carrier and Non-carrier Couples. Available at: http:\/\/www.ashg.org\/2012meeting\/abstracts\/fulltext\/f120121755.htm. Accessed on February 17,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib54","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1093\/pch\/16.3.e23","article-title":"Amish, Mennonite, and Hutterite genetic disorder database","volume":"16","author":"Payne","year":"2011","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jogc.2016.06.008_bib55","unstructured":"Biochemical Centre Laboratory London Ontario, 2016. Amish, Mennonite, Hutterite Genetic Disorder database. Available at: www.biochemgenetics.ca\/plainpeople. Accessed on March 28,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib56","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.06.008_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/pd.4459","article-title":"SMA carrier testing: a meta-analysis of differences in test performance by ethnic group","volume":"34","author":"MacDonald","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2016.06.008_bib58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmoldx.2010.11.012","article-title":"Population carrier screening for spinal muscular atrophy: a position statement of the Association for Molecular Pathology","volume":"13","author":"Muralidharan","year":"2011","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jogc.2016.06.008_bib60","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1701-2163(15)30205-X","article-title":"Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits","volume":"37","author":"Wilson","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.06.008_bib61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1701-2163(16)35055-1","article-title":"Fetal and perinatal autopsy in prenatally diagnosed fetal abnormalities with normal karyotype","volume":"33","author":"D\u00e9silets","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.06.008_bib62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gim.2013.125","article-title":"Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research","volume":"16","author":"Ioannou","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib63","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ejhg.2010.78","article-title":"Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening","volume":"18","author":"McClaren","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jogc.2016.06.008_bib64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/gim.2013.47","article-title":"ACMG position statement on prenatal\/preconception expanded carrier screening","volume":"15","author":"Grody","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib65","first-page":"15","article-title":"The changing landscape of carrier screening: expanding technology and options?","volume":"23","author":"McGowan","year":"2013","journal-title":"Health Matrix Clevel"},{"key":"10.1016\/j.jogc.2016.06.008_bib66","first-page":"350","article-title":"Development and performance of a comprehensive targeted sequencing assay for pan-ethnic screening of carrier status","volume":"16","author":"Tanner","year":"2014","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jogc.2016.06.008_bib67","first-page":"227","article-title":"Implementation and utilization of genetic testing in personalized medicine","volume":"7","author":"Abul-Husn","year":"2014","journal-title":"Pharmacogenomics Pers Med"},{"key":"10.1016\/j.jogc.2016.06.008_bib68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/AOG.0000000000000666","article-title":"Expanded carrier screening in reproductive medicine \u2013 points to consider","volume":"125","author":"Edwards","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.06.008_bib69","unstructured":"Morrison S, Allanson JE, Carroll JC. Direct to consumer genetic testing. Genetics Education Canada \u2013 Knowledge Organisation. Available at: www.geneticseducation.ca. Updated April 2015. Accessed on April 30, 2015."},{"key":"10.1016\/j.jogc.2016.06.008_bib70","unstructured":"CCMG Statement on Direct-To-Consumer Genetic Testing (January 20, 2011). Available at: www.ccmg-ccgm.org\/publications\/practice-guidelines-position-statements-and-reports.htm. Accessed on March 28,\u00a02016."},{"key":"10.1016\/j.jogc.2016.06.008_bib71","unstructured":"Quebec Health Regions, 2003. Available at: http:\/\/www.statcan.gc.ca\/pub\/82-221-x\/01103\/images\/jpg\/que_qc.jpg. Accessed on April 30, 2015."}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316393471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316393471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:03:16Z","timestamp":1716843796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216316393471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1701216316393471"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2016.06.008","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETIRED: Joint SOGC\u2013CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}